SavedAdd your journal

Journals / Epilepsi / 2016 / Cilt: 22 - Sayı: Suppl. 1

Epileptic Syndromes With Possible Immunological Mechanisms (Rasmussen Encephalitis, FIRES, West Syndrome, Landau-Kleffner Syndrome)

Olası İmmünolojik Mekanizmalı Epileptik Sendromlar (Rasmussen Ensefaliti, FIRES, West Sendromu, Landau-Kleffner Sendromu)

Demet KINAY
Pınar TEKTÜRK
Journal
Epilepsi
Pages
14–29
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These syndromes, such as Rasmussen encephalitis, FIRES, West syndrome, and Landau-Kleffner syndrome each of which are proceeding with severe epileptic encephalopathy are discussed with their physiopathological, clinical, EEG, laboratory, treatment and prognostic characteristics by the help of current literatüre.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Some of childhood epileptic syndromes reminds immunological etiologies with their good response to immuno-therapy and histopathological findings.
📊
Key Findings & Data:Some of childhood epileptic syndromes reminds immunological etiologies with their good response to immuno-therapy and histopathological findings.
💡
Conclusion & Impact:These syndromes, such as Rasmussen encephalitis, FIRES, West syndrome, and Landau-Kleffner syndrome each of which are proceeding with severe epileptic encephalopathy are discussed with their physiopathological, clinical, EEG, laboratory, treatment and prognostic characteristics by the help of current literatüre.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Some of childhood epileptic syndromes reminds immunological etiologies with their good response to immuno-therapy and histopathological findings. These syndromes, such as Rasmussen encephalitis, FIRES, West syndrome, and Landau-Kleffner syndrome each of which are proceeding with severe epileptic encephalopathy are discussed with their physiopathological, clinical, EEG, laboratory, treatment and prognostic characteristics by the help of current literatüre.

Özet

Çocukluk çağında görülen epileptik sendromlardan birkaçı immun tedaviye iyi yanıt vermeleriyle ve histopatolojik bulguları nedeniyle immunolojik nedenleri akla getirmektedir. Rasmussen ensefaliti, FIRES, West sendromu ve Landau-Klefner sendromu gibi, her biri çoğunluklaağır epileptik ensefalopati tablosuyla seyreden bu sendromlar, fizyopatoloji, klinik, EEG, laboratuvar, tedavi ve prognostik özellikleri açısındangüncel literatür eşliğinde incelenmiştir

🔖

Cite This Article

KINAY, D., TEKTÜRK, P. (2022). Epileptic Syndromes With Possible Immunological Mechanisms (Rasmussen Encephalitis, FIRES, West Syndrome, Landau-Kleffner Syndrome). Epilepsi, Cilt: 22 - Sayı: Suppl. 1, 14–29. https://ajindex.com/articles/501675

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Rasmussen T, Olszewskı J, Lloydsmıth D. Focal seizures due to chronic localized encephalitis. Neurology 1958;8(6):435–45. Andermann F. editor. Chronic encephalitis and epilepsy. Rasmussen’s syndrome. Boston: Butterworth-Heinemann; 1991. Hart Y. Rasmussen’s encephalitis. Epileptic Disord 2004;6(3):133–44.
  2. Andrews JM, Thompson JA, Pysher TJ, Walker ML, Hammond ME. Chronic encephalitis, epilepsy, and cerebrovascular immune complex deposits. Ann Neurol 1990;28(1):88–90.
  3. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis. Science 1994;265(5172):648–51.
  4. Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, Dichgans J, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen’s encephalitis. Neurology 2001;57(8):1511–4.
  5. Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, et al. Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002;131(1-2):179–85.
  6. Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight K, et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 2004;63(1):43– 50. Watson R, Jepson JE, Bermudez I, Alexander S, Hart Y, McKnight K, et al. Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology 2005;65(11):1802–4.
  7. Yang R, Puranam RS, Butler LS, Qian WH, He XP, Moyer MB, et al. Autoimmunity to munc-18 in Rasmussen’s encephalitis. Neuron 2000;28(2):375–83.
  8. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen’s encephalitis. Ann Neurol 2002;51(3):311–8.
  9. Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, et al. Astrocytes are a specific immunological target in Rasmussen’s encephalitis. Ann Neurol 2007;62(1):67–80.
  10. Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, Dornmair K, et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 2009;132(Pt 5):1236–46.
  11. Owens GC, Huynh MN, Chang JW, McArthur DL, Hickey MJ, Vinters HV, et al. Differential expression of interferon-γ and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Ne